These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 37269943

  • 1. NT-proBNP/cardiac troponin T ratio >7.5 on the second day of admission can differentiate Takotsubo from acute coronary syndrome with good accuracy.
    Rallidis LS, Iordanidis D, Papathanasiou KA, Simitsis P, Varounis C, Simou A, Kosmas N.
    Hellenic J Cardiol; 2024; 76():22-30. PubMed ID: 37269943
    [Abstract] [Full Text] [Related]

  • 2. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
    Fröhlich GM, Schoch B, Schmid F, Keller P, Sudano I, Lüscher TF, Noll G, Ruschitzka F, Enseleit F.
    Int J Cardiol; 2012 Feb 09; 154(3):328-32. PubMed ID: 22044675
    [Abstract] [Full Text] [Related]

  • 3. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A, Lubnow M, Müller T, Muders F, Holmer S, Riegger GA, Luchner A.
    Clin Chem Lab Med; 2010 Jun 09; 48(6):875-81. PubMed ID: 20441480
    [Abstract] [Full Text] [Related]

  • 4. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Lindholm D, James SK, Bertilsson M, Becker RC, Cannon CP, Giannitsis E, Harrington RA, Himmelmann A, Kontny F, Siegbahn A, Steg PG, Storey RF, Velders MA, Weaver WD, Wallentin L, PLATO Investigators.
    Clin Chem; 2017 Feb 09; 63(2):573-584. PubMed ID: 27932413
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
    Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM.
    Cardiovasc J S Afr; 2006 Feb 09; 17(2):60-6. PubMed ID: 16733598
    [Abstract] [Full Text] [Related]

  • 6. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.
    Am Heart J; 2013 May 09; 165(5):716-24. PubMed ID: 23622908
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA, Adiyaman A, Dambrink JE, Gosselink AM, Kedhi E, Roolvink V, Ottervanger JP, Van't Hof AW.
    Vasc Health Risk Manag; 2016 May 09; 12():471-476. PubMed ID: 27920547
    [Abstract] [Full Text] [Related]

  • 8. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657
    [Abstract] [Full Text] [Related]

  • 9. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M, Liao JK, Yan B, Li R, Zhang M, Yu CM.
    Int J Cardiol; 2013 Sep 10; 167(6):2813-9. PubMed ID: 22921817
    [Abstract] [Full Text] [Related]

  • 10. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C, Prontera C, Liga R, De Graaf MA, Gaemperli O, Lorenzoni V, Ragusa R, Marinelli M, Del Ry S, Rovai D, Giannessi D, Aguade-Bruix S, Clemente A, Bax JJ, Lombardi M, Sicari R, Zamorano J, Scholte AJ, Kaufmann PA, Knuuti J, Underwood SR, Clerico A, Neglia D.
    Arterioscler Thromb Vasc Biol; 2016 Apr 10; 36(4):757-64. PubMed ID: 26868212
    [Abstract] [Full Text] [Related]

  • 11. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB.
    Clin Chim Acta; 2007 Feb 10; 376(1-2):168-73. PubMed ID: 17011538
    [Abstract] [Full Text] [Related]

  • 12. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?
    Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS.
    Clin Chem; 2008 Apr 10; 54(4):747-51. PubMed ID: 18375487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
    Ogawa A, Seino Y, Yamashita T, Ogata K, Takano T.
    Circ J; 2006 Nov 10; 70(11):1372-8. PubMed ID: 17062956
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
    Stiermaier T, Santoro F, Graf T, Guastafierro F, Tarantino N, De Gennaro L, Caldarola P, Di Biase M, Thiele H, Brunetti ND, Möller C, Eitel I.
    Clin Res Cardiol; 2018 Jul 10; 107(7):597-606. PubMed ID: 29675571
    [Abstract] [Full Text] [Related]

  • 16. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF, Jiang L, Chen YY, Liu YH, Chen PY, Duan CY, Zeng LH, Fan HL, Wei XB, Guo W, Chen W, Li J, Li WS, Guo ZQ, Liu ZK, Tan N, Chen JY, He PC.
    BMC Cardiovasc Disord; 2021 Apr 21; 21(1):202. PubMed ID: 33882836
    [Abstract] [Full Text] [Related]

  • 17. Comparison of troponin and natriuretic peptides in Takotsubo syndrome and acute coronary syndrome: a meta-analysis.
    Couch LS, Garrard JW, Henry JA, Kotronias RA, Alaour B, De Maria GL, Channon KM, Banning AP, Lyon AR, Marber M, Kaier TE.
    Open Heart; 2024 Mar 19; 11(1):. PubMed ID: 38508657
    [Abstract] [Full Text] [Related]

  • 18. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
    Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, Stridsberg M, Venge P, Wallentin L.
    J Am Coll Cardiol; 2003 Dec 03; 42(11):1909-16. PubMed ID: 14662251
    [Abstract] [Full Text] [Related]

  • 19. The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes.
    Riezebos RK, Laarman GJ, Tijssen JGP, Verheugt FWA.
    Clin Chem Lab Med; 2011 Aug 03; 49(8):1359-1365. PubMed ID: 21692686
    [Abstract] [Full Text] [Related]

  • 20. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Aug 03; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.